Evidence map›Paper›PMID 33200421›Full record

ArticleThe EMBO journal2020

Mitochondrial Safeguard: a stress response that offsets extreme fusion and protects respiratory function via flickering-induced Oma1 activation.

Daisuke Murata, Tatsuya Yamada, Takeshi Tokuyama, Kenta Arai, Pedro M Quirós, Carlos López-Otín, Miho Iijima, Hiromi Sesaki

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Proteolytic control of mitochondrial protein translocases.Protein science : a publication of the Protein Society · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Molecular mechanisms of mitochondrial dynamics.Nature reviews. Molecular cell biology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Daisuke MurataDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-3829-6620
Tatsuya YamadaDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Takeshi TokuyamaDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kenta AraiDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pedro M QuirósDepartamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.
Carlos López-OtínDepartamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain.
Miho IijimaDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hiromi SesakiDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-6877-3929
Johns Hopkins University · USUniversidad de Oviedo · ES

Funding

Regulation of Intracellular SignalingR35GM131768 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Miho Iijima · 2019 to 2026
$4.0M
Mitochondrial Quality Control by Drp1R01GM123266 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SESAKI, HIROMI · 2018 to 2021
$1.4M
Regulation of Mitochondrial Division by Phosphatidic AcidR01GM130695 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SESAKI, HIROMI · 2019 to 2021
$933k
Adrienne Helis Malvin Medical Research FoundationDiana Helis Henry Medical Research FoundationHHS | NIH | National Institute of General Medical Sciences (NIGMS) GM130695NIGMS NIH HHS R01 GM123266NIGMS NIH HHS R01 GM130695NIGMS NIH HHS R35 GM131768Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (Kleberg Foundation)
6 · The paper itself

Abstract

The connectivity of mitochondria is regulated by a balance between fusion and division. Many human diseases are associated with excessive mitochondrial connectivity due to impaired Drp1, a dynamin-related GTPase that mediates division. Here, we report a mitochondrial stress response, named mitochondrial safeguard, that adjusts the balance of fusion and division in response to increased mitochondrial connectivity. In cells lacking Drp1, mitochondria undergo hyperfusion. However, hyperfusion does not completely connect mitochondria because Opa1 and mitofusin 1, two other dynamin-related GTPases that mediate fusion, become proteolytically inactivated. Pharmacological and genetic experiments show that the activity of Oma1, a metalloprotease that cleaves Opa1, is regulated by short pulses of the membrane depolarization without affecting the overall membrane potential in Drp1-knockout cells. Re-activation of Opa1 and Mitofusin 1 in Drp1-knockout cells further connects mitochondria beyond hyperfusion, termed extreme fusion, leading to bioenergetic deficits. These findings reveal an unforeseen safeguard mechanism that prevents extreme fusion of mitochondria, thereby maintaining mitochondrial function when the balance is shifted to excessive connectivity.

Indexed as

AnimalsDynaminsEnergy MetabolismGene Knockout TechniquesGTP PhosphohydrolasesHEK293 CellsHumansMetalloendopeptidasesMetalloproteasesMiceMitochondriaMitochondrial DynamicsMitochondrial Membrane Transport ProteinsMitochondrial ProteinsStress, PhysiologicalTranscriptomeDNM1L protein, humanDynaminsGTP PhosphohydrolasesMetalloendopeptidasesMetalloproteasesMfn1 protein, humanMitochondrial Membrane Transport ProteinsMitochondrial Proteinsmolecule metalloprotease-related protein-1, humanOMA1 protein, mouseDrp1mitochondrial fusionmitofusinOma1Opa1

Identifiers

PMID33200421
PMCPMC7737612
OpenAlexW3105015518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.